Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00367224 · ClinicalTrials.gov registry record · NA
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00367224 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 17 participants.
The verdict
NCT00367224, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if vitiligo patients develop tolerance to ultraviolet light therapy, a type of treatment available for vitiligo.
Interventions
- PROCEDURE Skin biopsies
- PROCEDURE 6 to 9 ultraviolet B treatments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00367224
The ClinicalTrials.gov registry entry for NCT00367224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Skin biopsies is the first listed.
NCT00367224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00367224 about?
NCT00367224 is a clinical study titled "Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo". The purpose of this study is to determine if vitiligo patients develop tolerance to ultraviolet light therapy, a type of treatment available for vitiligo.
What is the current status of trial NCT00367224?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2006-01. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00367224?
The interventions under investigation include: Skin biopsies (PROCEDURE), 6 to 9 ultraviolet B treatments (PROCEDURE).
Who is sponsoring clinical trial NCT00367224?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.